MagnetTx Oncology Solutions Ltd

MagnetTx Oncology Solutions is a medical device manufacturer specializing in advanced radiotherapy systems for cancer treatment. The company's flagship product is the Aurora-RT, a next-generation LINAC-MR (linear accelerator-magnetic resonance) hybrid system that integrates high-quality MR imaging with a 6 MV linear accelerator for targeted cancer radiation therapy. The Aurora-RT combines pre-treatment MR imaging for precise patient alignment with real-time MR imaging during beam delivery, enabling adaptive radiotherapy and tumor tracking. Key advantages include minimal electron return effect, superior soft-tissue contrast compared to traditional Cone Beam CT guidance systems, and concurrent imaging during treatment delivery. The device features an open-concept design, modular treatment table capabilities, and helium gas cooling (eliminating liquid helium dependency). Aurora-RT is FDA-approved, CE-marked, and UKCA-approved for use in the United States, European Union, and United Kingdom markets. The system is designed with patient comfort and safety as primary considerations, and operates as an open-source platform compatible with multiple treatment planning systems. MagnetTx serves cancer centers and radiotherapy facilities requiring advanced imaging-guided radiation oncology capabilities.